[BIG TECH]■ STORY TIMELINE
DASSAULT SYSTÈMES ACQUIRES DRUG TRIAL SOFTWARE FIRM
Dassault Systèmes SE is acquiring ArisGlobal, a drug trial software maker, for up to $2 billion. The deal marks the French company's continued expansion into life sciences software.
Bloomberg Tech+0m
Dassault Systèmes SE will buy drug trial software maker ArisGlobal for as much as $2 billion as the French firm expands…
Bloomberg Tech+5d 14h
Gainwell Technologies LLC is in discussions with investors to replace almost $5.7 billion of leveraged loans, a deal tha…